Harlow on Healthcare episode NOW on Demand. Host David Harlow talks with Dara Richardson-Heron M.D., chief engagement officer of the All of Us Research Program at the National Institutes of Health.
Read More
By Daniel Marino – With recent changes to the Medicare Shared Savings Program, all accountable care organizations need to pay closer attention to their compliance obligations and be prepared to make changes quickly.
By John Halamka MD – In a previous blog post, I shared an excerpt from the new book that Paul Cerrato and I just completed, The Transformative Power of Mobile Medicine. Here is a second excerpt from Chapter 3, “Exploring the Strengths and Weaknesses of Mobile Health Apps.”
By Marty Callahan – Financial challenges again ranked as the top concern for hospital CEOs in the most recent ACHE survey of hospital leaders. Medicaid reimbursement (including adequacy and timeliness of payments) was a top concern of 71 percent of hospital CEOs.
New Dr. Nick: The Incrementalist Episode NOW on Demand with host Dr. Nick and guest Mark Scrimshire a fellow Walking Gallery member and Entrepreneur in Residence at NewWave and on assignment as Medicare Blue Button 2.0 Innovator at CMS.
By William Hyman – On December 18th CMS presented a webinar on the Promoting Interoperability Program as applied to Inpatient Prospective Payments. Among the other content the webinar included changes from 2018 to 2019, and from 2019 to 2020.
By Julie Appleby & Barbara Feder Ostrov – As of Jan. 1, in the name of transparency, the Trump administration required that all hospitals post their list prices online. But what is popping up on medical center websites is a dog’s breakfast of medical codes, abbreviations and dollar signs —
By Chris Muir & James Daniel – It’s been a little more than a year since the Docket app won the Office of the National Coordinator for Health IT’s Move Health Data Forward (MHDF) Challenge, focused on helping consumers consolidate and share their health data.
By Scott Gottlieb MD & Gerald Dal Pan MD, MHS – The US FDA is an information-driven agency that requires robust data to make regulatory decisions. One of our key obligations is to analyze large quantities of data related to the safety and effectiveness of medical products…